Oramed Pharmaceuticals
ORMP
#9022
Rank
โ‚น16.77 B
Marketcap
โ‚น409.91
Share price
-0.23%
Change (1 day)
128.84%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น77.40. In 2024 the company made an earnings per share (EPS) of -โ‚น45.86 a decrease over its 2023 EPS that were of โ‚น13.38.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-261.36%
2024-โ‚น45.86-442.86%
2023โ‚น13.38-114.89%
2022-โ‚น89.8220.51%
2021-โ‚น74.5339.29%
2020-โ‚น53.51-31.71%
2019-โ‚น78.35-4.65%
2018-โ‚น82.178.86%
2017-โ‚น75.48-9.2%
2016-โ‚น83.1329.85%
2015-โ‚น64.028.06%
2014-โ‚น59.245.08%
2013-โ‚น56.373.51%
2012-โ‚น54.46137.5%
2011-โ‚น22.93-60%
2010-โ‚น57.33-0%
2009-โ‚น57.33-16.67%
2008-โ‚น68.80-25%
2007-โ‚น91.73700%
2006-โ‚น11.47303.56%
2005-โ‚น2.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น410.43 430.30%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น244.58 216.01%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น583.81-854.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น18.15-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.67-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel